Literature DB >> 2258608

Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens.

R Korngold1, P J Wettstein.   

Abstract

Immunodominance controls the generation of CTL in the C57BL/6By (B6) anti-BALB.B H-2b-matched strain combination. Despite the potential of responding to numerous individual minor histocompatibility (H) Ag on BALB.B APC, the focus of the CTL response is largely specific for only a limited number of target Ag. These minor H Ag could be distinguished by their differential expression on a panel of target cells from the CXB recombinant inbred strains, the E, G, I, J, and K (all H-2b), which express different composites of the original BALB minor H Ag. A hierarchy was observed in which first-order immunodominant Ag were present on both CXBK and CXBG cells, whereas second-order dominant Ag were found on CXBE, CXBJ, and CXBI cells. To test whether immunodominance also plays a role in the development of lethal graft-vs-host disease (GVHD) directed to multiple minor H Ag, B6 T cells were transplanted along with T cell depleted bone marrow, to irradiated (825 rad) recipients of either the BALB.B or CXB recombinant inbred strains. The results indicate that a hierarchy of immunodominance does exist in GVHD, but it differs from that predicted from the in vitro CTL studies. GVHD was observed in BALB.B, CXBE, CXBI, and CXBJ recipients, but not in CXBG and CXBK recipients. Presensitization of B6 donor mice to CXBG or CXBK splenocytes 3 wk before transplant did not significantly increase the overall GVHD potential in the corresponding CXBG or CXBK recipients. Evidence for second-order immunodominance was provided by the transfer of CXBE T cells and ATBM to irradiated CXBG and BALB.B recipients with resultant, potent GVHD.

Entities:  

Mesh:

Year:  1990        PMID: 2258608

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.

Authors:  C Perreault; J Jutras; D C Roy; J G Filep; S Brochu
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

Authors:  E Z Wolpert; M Petersson; B J Chambers; J K Sandberg; R Kiessling; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.

Authors:  Jenny Zilberberg; Danielle McElhaugh; Loise N Gichuru; Robert Korngold; Thea M Friedman
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

4.  Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.

Authors:  Antonio Pierini; Lucrezia Colonna; Maite Alvarez; Dominik Schneidawind; Hidekazu Nishikii; Jeanette Baker; Yuqiong Pan; Mareike Florek; Byung-Su Kim; Robert S Negrin
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

5.  Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Authors:  Paul J Martin; David M Levine; Barry E Storer; Edus H Warren; Xiuwen Zheng; Sarah C Nelson; Anajane G Smith; Bo K Mortensen; John A Hansen
Journal:  Blood       Date:  2016-11-21       Impact factor: 22.113

6.  Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.

Authors:  Koji Kato; Shuaiying Cui; Rork Kuick; Shin Mineishi; Elizabeth Hexner; James L M Ferrara; Stephen G Emerson; Yi Zhang
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-29       Impact factor: 5.742

7.  In vivo imaging of differences in early donor cell proliferation in graft-versus-host disease hosts with different pre-conditioning doses.

Authors:  Myung Geun Song; Bora Kang; Ji Yeong Jeon; Jun Chang; Seungbok Lee; Chang-Ki Min; Hyewon Youn; Eun Young Choi
Journal:  Mol Cells       Date:  2012-01-03       Impact factor: 5.034

8.  Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

Authors:  C A van Els; J D'Amaro; J Pool; E Blokland; A Bakker; P J van Elsen; J J van Rood; E Goulmy
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.

Authors:  S Shenoy; K Desch; B Duffy; P Thorson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.

Authors:  M Bruley Rosset; V Tieng; D Charron; A Toubert
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.